Emergence of dysfunctional neutrophils with a defect in arginase-1 release in severe COVID-19
Authors:
- Amrita DwivediADAmrita Dwivedi
- Makala CarrollMCMakala Carroll
- Bahareh KhosraviBKBahareh Khosravi
- Isabella BattenIBIsabella Batten
- Robert Seán BallantineRBRobert Seán Ballantine
- Laura O’DOhertyLOLaura O’DOherty
- Angel Mary GeorgeAGAngel Mary George
- Jacklyn SuiJSJacklyn Sui
- Heike C. HawerkampHHHeike C. Hawerkamp
- Padraic G. FallonPFPadraic G. Fallon
Open Access
- 10 September 2024
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 9 (17)
Abstract
Neutrophilia occurs in patients infected with SARS-CoV-2 (COVID-19) and is predictive of poor outcomes. Here, we link heterogenous neutrophil populations to disease severity in COVID-19. We identified neutrophils with features of cellular aging and immunosuppressive capacity in mild COVID-19 and features of neutrophil immaturity and activation in severe disease. The low-density neutrophil (LDN) number in circulating blood correlated with COVID-19 severity. Many of the divergent neutrophil phenotypes in COVID-19 were overrepresented in the LDN fraction and were less detectable in normal-density neutrophils. Functionally, neutrophils from patients with severe COVID-19 displayed defects in neutrophil extracellular trap formation and reactive oxygen species production. Soluble factors secreted by neutrophils from these patients inhibited T cell proliferation. Neutrophils from patients with severe COVID-19 had increased expression of arginase-1 protein, a feature that was retained in convalescent patients. Despite this increase in intracellular expression, there was a reduction in arginase-1 release by neutrophils into serum and culture supernatants. Furthermore, neutrophil-mediated T cell suppression was independent of arginase-1. Our results indicate the presence of dysfunctional, activated, and immature neutrophils in severe COVID-19.Keywords
Funding Information
- Irish Research Council, Science Foundation Ireland, Health research board, Meath Foundation and Vifor-CSL (GOIPG/2020/222,20/SPP/3685,COV19-2020-071,RG122/2021)
This publication has 73 references indexed in Scilit:
- Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19Biomedicine & Pharmacotherapy, 2021
- Emergence of immunosuppressive LOX-1+ PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndromeJournal of Leukocyte Biology, 2021
- Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell CompartmentCell, 2020
- Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19Cell, 2020
- A Flow Cytometry‐Based Assay for High‐Throughput Detection and Quantification of Neutrophil Extracellular Traps in Mixed Cell PopulationsCytometry Part A, 2018
- Isolation and Characterization of Low- vs. High-Density Neutrophils in Cancer2016
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Neutrophil‐Related Gene Expression and Low‐Density Granulocytes Associated With Disease Activity and Response to Treatment in Antineutrophil Cytoplasmic Antibody–Associated VasculitisArthritis & Rheumatology, 2015
- FlowSOM: Using self‐organizing maps for visualization and interpretation of cytometry dataCytometry Part A, 2015
- IL‐8 induces exocytosis of arginase 1 by neutrophil polymorphonuclears in nonsmall cell lung cancerInternational Journal of Cancer, 2009